Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency (original) (raw)
- Article
- Published: 26 April 2009
- Aaron Y L Cheung1,3,
- Natalie Farra1,3,
- Kausalia Vijayaragavan4 nAff6,
- Cheryle A Séguin1,2 nAff6,
- Jonathan S Draper1 nAff6,
- Peter Pasceri1,
- Irina A Maksakova5,
- Dixie L Mager5,
- Janet Rossant1,2,3,
- Mickie Bhatia4 &
- …
- James Ellis1,2,3
Nature Methods volume 6, pages 370–376 (2009)Cite this article
- 7178 Accesses
- 220 Citations
- 15 Altmetric
- Metrics details
Abstract
Induced pluripotent stem (iPS) cells may be of use in regenerative medicine. However, the low efficiency of reprogramming is a major impediment to the generation of patient-specific iPS cell lines. Here we report the first selection system for the isolation of human iPS cells. We developed the EOS (Early Transposon promoter and Oct-4 (Pou5f1) and Sox2 enhancers) lentiviral vector to specifically express in mouse and human embryonic stem cells but not in primary fibroblasts. The bicistronic EOS vector marked emerging mouse and human iPS cell colonies with EGFP, and we used puromycin selection to aid the isolation of iPS cell lines that expressed endogenous pluripotency markers. These lines differentiated into cell types from all three germ layers. Reporter expression was extinguished upon differentiation and therefore monitored the residual pluripotent cells that form teratomas. Finally, we used EOS selection to establish Rett syndrome–specific mouse and human iPS cell lines with known mutations in MECP2.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006).
Article CAS Google Scholar - Okita, K., Ichisaka, T. & Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313–317 (2007).
Article CAS Google Scholar - Wernig, M. et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318–324 (2007).
Article CAS Google Scholar - Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
Article CAS Google Scholar - Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
Article CAS Google Scholar - Park, I.H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).
Article CAS Google Scholar - Ellis, J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 16, 1241–1246 (2005).
Article CAS Google Scholar - Maksakova, I.A. & Mager, D.L. Transcriptional regulation of early transposon elements, an active family of mouse long terminal repeat retrotransposons. J. Virol. 79, 13865–13874 (2005).
Article CAS Google Scholar - Okumura-Nakanishi, S., Saito, M., Niwa, H. & Ishikawa, F. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J. Biol. Chem. 280, 5307–5317 (2005).
Article CAS Google Scholar - Tomioka, M. et al. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res. 30, 3202–3213 (2002).
Article CAS Google Scholar - Peerani, R. et al. Niche-mediated control of human embryonic stem cell self-renewal and differentiation. EMBO J. 26, 4744–4755 (2007).
Article CAS Google Scholar - Stewart, M.H. et al. Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat. Methods 3, 807–815 (2006).
Article CAS Google Scholar - Bendall, S.C. et al. IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015–1021 (2007).
Article CAS Google Scholar - Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101–106 (2008).
Article CAS Google Scholar - Wernig, M., Meissner, A., Cassady, J.P. & Jaenisch, R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10–12 (2008).
Article CAS Google Scholar - Takahashi, K., Okita, K., Nakagawa, M. & Yamanaka, S. Induction of pluripotent stem cells from fibroblast cultures. Nat. Protoc. 2, 3081–3089 (2007).
Article CAS Google Scholar - Brambrink, T. et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151–159 (2008).
Article CAS Google Scholar - Stadtfeld, M., Maherali, N., Breault, D.T. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008).
Article CAS Google Scholar - Lowry, W.E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 105, 2883–2888 (2008).
Article CAS Google Scholar - Bienvenu, T. & Chelly, J. Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nat. Rev. Genet. 7, 415–426 (2006).
Article CAS Google Scholar - Shahbazian, M. et al. Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35, 243–254 (2002).
Article CAS Google Scholar - Park, I.H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008).
Article CAS Google Scholar - Dimos, J.T. et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218–1221 (2008).
Article CAS Google Scholar - Ebert, A.D. et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277–280 (2008).
Article Google Scholar - Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
Article CAS Google Scholar - Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
Article CAS Google Scholar - Shi, Y. et al. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525–528 (2008).
Article CAS Google Scholar - Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 5856–5861 (2008).
Article CAS Google Scholar - Buzina, A. et al. β-Globin LCR and intron elements cooperate and direct spatial reorganization for gene therapy. PLoS Genet. 4, e1000051 (2008).
Article Google Scholar - Yeom, Y.I. et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122, 881–894 (1996).
CAS PubMed Google Scholar
Acknowledgements
We thank H.R. Schöler (Max Planck Institute for Molecular Biomedicine) for providing Oct-4 promoter plasmid, T. Kitamura (Institute of Medical Science, University of Tokyo) for Plat-E cells, B. Alman and A. Lin for human fibroblast isolation and I.H. Park for advice on human iPS cell isolation. We gratefully acknowledge the assistance of T. Thompson at the Ontario Human iPS Cell Facility, SickKids The Centre for Applied Genomics Facility, SickKids ES Facility, SickKids Flow Facility and the Centre for Modeling Human Disease pathology core. This work was supported by grants from the Canadian Institutes of Health Research (MOP-10825 to D.L.M., MOP-77803 to J.R., MOP-81129 and IG1-94505 to J.E., and RMF-92090 to J.E. and D.L.M.), the Stem Cell Network (to J.R., M.B. and J.E.), the Ontario Ministry of Research and Innovation (to J.R. and J.E. for the Ontario Human IPS Cell Facility), and the International Rett Syndrome Foundation (to J.E.). A.H. is supported by a Restracomp Award from SickKids Hospital, A.Y.L.C. by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada, N.F. by an Ontario Council of Graduate Studies Master's Autism Scholars Award and the Ontario Student Opportunity Trust Funds Hayden Hantho Award and C.A.S. by the Stem Cell Network and the Juvenile Diabetes Research Foundation.
Author information
Author notes
- Kausalia Vijayaragavan, Cheryle A Séguin & Jonathan S Draper
Present address: Present addresses: Department of Regenerative Cardiology, Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (K.V.), Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, The University of Western Ontario, London, Ontario, Canada (C.A.S.) and McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote Centre for Learning and Discovery, Hamilton, Ontario, Canada (J.S.D.).,
Authors and Affiliations
- Developmental and Stem Cell Biology Program, Toronto, Ontario, Canada
Akitsu Hotta, Aaron Y L Cheung, Natalie Farra, Cheryle A Séguin, Jonathan S Draper, Peter Pasceri, Janet Rossant & James Ellis - Ontario Human iPS Cell Facility, SickKids, Toronto, Ontario, Canada
Akitsu Hotta, Cheryle A Séguin, Janet Rossant & James Ellis - Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
Aaron Y L Cheung, Natalie Farra, Janet Rossant & James Ellis - and Department of Biochemistry, McMaster Stem Cell and Cancer Research Institute, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
Kausalia Vijayaragavan & Mickie Bhatia - and Department of Medical Genetics, Terry Fox Laboratory, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada
Irina A Maksakova & Dixie L Mager
Authors
- Akitsu Hotta
You can also search for this author inPubMed Google Scholar - Aaron Y L Cheung
You can also search for this author inPubMed Google Scholar - Natalie Farra
You can also search for this author inPubMed Google Scholar - Kausalia Vijayaragavan
You can also search for this author inPubMed Google Scholar - Cheryle A Séguin
You can also search for this author inPubMed Google Scholar - Jonathan S Draper
You can also search for this author inPubMed Google Scholar - Peter Pasceri
You can also search for this author inPubMed Google Scholar - Irina A Maksakova
You can also search for this author inPubMed Google Scholar - Dixie L Mager
You can also search for this author inPubMed Google Scholar - Janet Rossant
You can also search for this author inPubMed Google Scholar - Mickie Bhatia
You can also search for this author inPubMed Google Scholar - James Ellis
You can also search for this author inPubMed Google Scholar
Contributions
A.H., D.L.M. and J.E. conceived the project; I.A.M. provided reagents; A.H., M.B., J.R. and J.E. designed experiments; A.H. developed the EOS vectors and performed the iPS cell reprogramming experiments; A.Y.L.C. and N.F. performed the Rett syndrome iPS cell experiments; K.V. and J.S.D. performed the hES cell experiments; C.A.S. and P.P. performed the teratoma experiments; A.H., J.R., M.B. and J.E. wrote the manuscript.
Corresponding author
Correspondence toJames Ellis.
Supplementary information
Rights and permissions
About this article
Cite this article
Hotta, A., Cheung, A., Farra, N. et al. Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency.Nat Methods 6, 370–376 (2009). https://doi.org/10.1038/nmeth.1325
- Received: 13 January 2009
- Accepted: 30 March 2009
- Published: 26 April 2009
- Issue Date: May 2009
- DOI: https://doi.org/10.1038/nmeth.1325